Keith Sullivan, MD, the James B. Wyngaarden Distinguished Professor of Medicine (Hematologic Malignancies and Cellular Therapy), is the recipient of the American Society for Transplantation and Cellular Therapy's 2020 Lifetime Achievement Award.

Duke study, led by Keith Sullivan, MD, shows stem cell transplant is better than drug therapy for scleroderma. The research was published in the New England Journal of Medicine on Jan. 4.

Subscribe to SullivanKeith